Producer
Kerry Group plc (Inhalation Lactose)
Irish food and pharmaceutical ingredients company (ISE/LSE: KYG, HQ Tralee County Kerry; ~€8B revenue); Kerry's pharmaceutical ingredients division produces specialty lactose grades including limited inhalation-grade lactose monohydrate. Kerry is a distant third in inhalation lactose behind Meggle and DFE Pharma — with <10% of the inhalation lactose market — but represents geographic diversification for pharmaceutical manufacturers concerned about dual Meggle/DFE Pharma concentration in Germany/Netherlands. Kerry's inhalation lactose comes from its Irish dairy operations and pharmaceutical lactose processing capabilities.
1
Inputs supplied
1
Goods downstream
0
Facilities
0
Stories
What they make
1 input Kerry Group plc (Inhalation Lactose) supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something Kerry Group plc (Inhalation Lactose) makes — pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map — where this supply-chain role fits within their broader business.
Taste & Nutrition
80%Consumer Foods
15%Pharmaceutical Ingredients
5%
Intelligence
What's known
Sourced claims about this company's role in supply chains — chokepoints, concentration, incidents, dual-use connections.
Did you know2024
Kerry Group is primarily known globally as a food taste and nutrition company — it supplies flavor systems, functional dairy ingredients, and plant proteins to virtually every major food manufacturer on earth (Nestle, Unilever, PepsiCo). What most food industry observers do not know is that the same Irish dairy processing infrastructure that yields Kerry's food ingredients also produces pharmaceutical-grade inhalation lactose for dry powder inhalers. A single dairy stream — Irish milk — ends up in both breakfast cereals and asthma inhaler carriers, making Kerry a rare company whose core food business quietly backstops a pharmaceutical supply chain. Kerry holds roughly <10% of the inhalation lactose market behind Meggle and DFE Pharma, but represents meaningful geographic diversification away from the German/Dutch duopoly.
Kerry Group plc ↗Origin2023
Kerry Group was founded in 1972 as a dairy co-operative in County Kerry, Ireland, initially processing milk from local farms into butter and dairy products. As Kerry industrialized its dairy processing, it accumulated the lactose refining capability needed for pharmaceutical-grade excipients — the same whey and lactose streams from cheesemaking that were once a low-value byproduct became the feedstock for specialty pharmaceutical lactose. Kerry entered pharmaceutical ingredients as a natural extension of dairy processing, not a deliberate pharma strategy.
Kerry Group plc ↗